Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): a phase II study (NIRA-PANC)
Saved in:
| Published in: | The Oncologist |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|